In this review
Put an actual supply beside each price
The current carousel advertises semaglutide injections from $99, tirzepatide injections from $179 and oral options from $149. The oral description names semaglutide or tirzepatide without identifying a complete selected formulation. Confirm the actual medicine, quantity and supplied period before treating those numbers as comparable monthly bills. [1]
The selected pricing, inclusions and after-sign-up FAQ answers all currently repeat cash-payment information. They do not settle the total, renewal or clinical inclusions. I would obtain those details directly before submitting a treatment request, rather than rely on an older promotion or assume a crossed-out rate controls the next purchase. [1]
Align total due and repeating charges in the GLP-1 total-cost planner.
Separate the prescription from the approval claim
The home page broadly says FDA-approved medication. That statement does not identify which specific approved brand, dosage form or preparation a patient would receive. The telehealth consent separately addresses compounded prescriptions and acknowledges that they are not FDA-approved. Establish the actual prescription rather than infer approval from the active ingredient name. [1] [3]
If the offered medicine is compounded, brand-trial results and oral-versus-injectable assumptions should not be transferred to it. Patient-specific compounding conditions still apply after shortage resolution. The listed partner pharmacies do not verify the actual dispenser or a particular batch for an order. [2] [4] [5]
Keep a measured treatment outcome separate from a service listing with the GLP-1 lean-mass evidence.
The terms permit recurring charges and early payment
The terms allow charging when a treatment request is submitted, with care beginning after the required onboarding and provider approval. Subscription payments recur at the selected service’s disclosed intervals. They continue unless cancellation notice arrives before the charge; the next applicable rate may change under the pricing provisions. [2]
Processed orders may be ineligible for refunds, and discounted purchases may be nonrefundable. Obtain the referenced billing/returns policy and the actual nonapproval, cancellation and shipment stages before paying. The forty-eight-hour appointment-cancellation restriction is not a general prescription return window. No unconditional medication trial is established. [2]
Compare another review-stage financial commitment in our Sunlight cancellation review.
Compare another consultation and refund arrangement in our EverFit Medical care-and-order review.
Compare another recurring purchase and cancellation arrangement in our Vytora Health purchase-terms review.
Medical access needs a usable appointment arrangement
Velvet advertises 24/7 access to its medical team and same-day visits. The consent preserves independent prescribing judgment and recognizes the limits of remote assessment. Neither feature guarantees an instant reply, a prescription or a scheduled dietitian appointment. Confirm who handles follow-up and what is included in the selected plan. [1] [3]
Terms limit particular services by state despite a broader nationwide statement. Confirm the chosen service before paying, along with supply and delivery arrangements. I would compare Velvet after those practical details are clear, keeping celebrity endorsements and before-and-after stories separate from evidence for an individual prescription. [1] [2]
Compare a different appointment-led service in our Form Health continuing-care review.
Understanding the cost
Current as-low-as figures: semaglutide injection $99, tirzepatide injection $179, oral GLP-1 $149. No complete supplied period, renewal price or selected invoice established. Confirm actual drug/formulation, total due, fees and recurring terms; no old crossed-out price imported.
Build your cost estimateSources
- Velvet Rx: current injectable/oral catalogue, starting prices and expanded care/pricing FAQs
- Velvet Rx: full payment, renewal, processed-order refund and appointment terms
- Velvet Rx: clinical assignment, telehealth limits and conditional compounding consent
- FDA: compounded drugs and premarket approval limits
- FDA: patient-specific GLP-1 compounding conditions after shortage resolution
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.